Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion

Planned Parenthood: Supply Induced Demand for Abortion in the US

Abstract

The rate and number of induced abortions in the US has declined steadily for nearly three decades. In contrast to this overall reduction, Planned Parenthood Federation of America abortion providers exhibit a persistent increase in both abortions and their market share percentage of total abortion procedures. For the period 1995-2014, estimated annual and cumulative excess abortions are calculated (Planned Parenthood Abortion Inflation Effect—PPAIE) to indicate the number of abortions which would have been averted if the PP utilization experience had been identical to that of Non-PP abortion providers. PP excess abortions grew steadily each year from 21,000 in 1996 to 258,200 in 2014, 28% of total abortions that year. The cumulative number of abortions added by the PPAIE from 1995-2014 was 3,025,560 or 12.5% of the 24,112,600 performed. Planned Parenthood has had a long-term and accelerating inflationary effect on the incidence and prevalence of abortion in the US.

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Abortion Reporting: Kentucky (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Alabama (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Virginia (2024)

October 5, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image